Neutralization titer kinetics
For participants in the monoclonal antibody COV-2069 trial, the median half-life of the neutralization titer was 26 days. For vaccinated individuals in the COVE trial, the estimated half-life was 70 days. The predicted nAb kinetics of 10 randomly selected COV-2069 and COVE participants over the course of their respective follow-up periods are given in Fig. 